About Matthew Robinson
Matthew Robinson is the CTO specializing in machine learning applications in drug discovery, with a strong background in computational chemistry and leadership in biotech startups.
Known information
Matthew Robinson serves as the Chief Technology Officer (CTO), where he applies his expertise in machine learning to the field of drug discovery. He holds a PhD and has a solid foundation in computational chemistry. Robinson has played a pivotal role in the development of PostEra’s Manifold platform, which leverages artificial intelligence for medicinal chemistry. His career includes significant contributions to open-science initiatives and leading technical teams in various biotech startups. Additionally, Robinson has authored several research publications focused on the integration of AI technologies in the realm of medicinal chemistry.
About PostEra
PostEra, based in Boston, MA, leverages machine learning to enhance medicinal chemistry, focusing on drug discovery and delivery within the healthcare industry.